Vasostrict — Class II drug recall D-0232-2024
Ongoing recall by Par Sterile Products LLC, reported 2024-01-24, distributed nationwide. Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limi
| Recall number | D-0232-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Par Sterile Products LLC, Rochester, MI, United States |
| Recall initiated | 2024-01-11 |
| Classified | 2024-01-16 |
| Reported by FDA | 2024-01-24 |
| Distributed | Nationwide (US) |
| Quantity | 1,721 cartons |
| Reason classes | potency, specification failure |
| NDC | 42023-0164, 42023-0164-01, 42023-0164-10, 42023-0164-25, 42023-0190, 42023-0190-01, 42023-0219, 42023-0219-01, 42023-0219-10, 42023-0237, 42023-0237-01, 42023-0237-10, 42023-0268, 42023-0268-01, 42023-0268-10 |
| Lot numbers | 66702 |
| Expiration dates | 2025-02 |
Product
Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready to Use, For Intravenous Infusion, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-237-10
Reason for recall
Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0232-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.